Skip to main content

Table 3 Multivariate analysis for LFFS, DMFS and OS

From: The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery

 

LFFS

DMFS

OS

Characteristic

HR (95 % CI)

P*

HR (95 % CI)

p

HR (95 % CI)

 

Age (>50 vs. ≤50)

 

0.980

 

0.774

 

0.210

Gender

 

0.602

 

0.780

 

0.794

Location

 

0.560

 

0.453

 

0.506

Histology

 

0.621

 

<0.001

 

<0.001

 Rhabdomyosarcoma

  

1.00

 

1.00

 

 Fibrosarcoma

  

0.128 (0.029–0.569)

0.012

0.142 (0.039–0.510)

0.003

 MFH

  

0.574 (0.281–1.174)

0.088

0.516 (0.254–1.047)

0.067

 Liposarcoma

  

0.161 (0.069–0.378)

<0.001

0.186 (0.088–0.392)

<0.001

 Others

  

0.407 (0.154–1.074)

0.074

0.426 (0.169–1.073)

0.070

Tumor size (cm)

 

0.033

 

0.066

 

0.003

 ≤5

1.00

   

1.00

 

 >5

1.815 (1051–3.138)

   

2.638 (1.392–4.998)

 

Grade

 

0.147

 

0.259

 

0.400

Margin status

 

0.002

 

0.143

 

<0.001

 Negative

1.00

 

1.00

 

1.00

 

 Positive

2.595 (1.432–4.702)

 

2.187 (1.055–4.536)

 

3.942 (2.233–6.959)

 

Lymph node status

 

0.909

 

0.272

 

0.582

Chemotherapy

 

0.687

 

0.894

 

0.719

Radiotherapy

 

0.001

 

0.769

 

0.017

 No

1.00

   

1.00

 

 Yes

0.408 (0.235–0.707)

   

0.512 (0.296–0.886)

 
  1. Abbreviations: HR hazard ratio, CI confidence interval, OS overall survival, LFFS local failure-free survival, DMFS distant metastasis-free survival
  2. *Determined by Cox logistic regression method